Church & Dwight Co. (CHD)
(Delayed Data from NYSE)
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.16 USD
-0.48 (-0.47%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $102.11 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Factors Setting the Tone for Blue Apron's (APRN) Q1 Earnings
by Zacks Equity Research
Blue Apron's (APRN) first-quarter 2020 performance is likely to reflect higher restructuring charges. Nonetheless, focus on innovation bodes well.
Factors to Know Ahead of Archer Daniels' (ADM) Q1 Earnings
by Zacks Equity Research
Although Archer Daniels' (ADM) Q1 performance is likely to have gained from the nutrition unit, softness in the Ag Services and Oilseeds, and Carbohydrate Solutions units might have been a drag.
Will Strong Brand Portfolio Aid PepsiCo's (PEP) Q1 Earnings?
by Zacks Equity Research
PepsiCo's (PEP) first-quarter 2020 results are likely to reflect gains from strong product and geographic portfolios. The company is likely to have benefitted from pantry loading amid coronavirus crisis.
Church & Dwight (CHD) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Keurig Dr Pepper's (KDP) Q1 Earnings?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter 2020 performance is likely to reflect gains from innovation and marketing of key brands. However, growth investments are likely to entail high costs.
Things You Must Know Ahead of Philip Morris' (PM) Q1 Earnings
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2020 performance is likely to reflect favorable pricing and gains from RRPs. However, soft cigarette volumes might have been a concern.
3 Reasons Why Growth Investors Shouldn't Overlook Church & Dwight (CHD)
by Zacks Equity Research
Church & Dwight (CHD) could produce exceptional returns because of its solid growth attributes.
Keurig Dr Pepper (KDP) Unveils Strategic Refinancing Program
by Zacks Equity Research
Keurig Dr Pepper (KDP) announces a strategic refinancing program with an aim to extend its debt maturities and enhance liquidity position.
Things You Must Know Ahead of Lamb Weston's (LW) Q3 Earnings
by Zacks Equity Research
Strength in the Global segment is likely to get reflected in Lamb Weston's (LW) third-quarter fiscal 2020 performance. However, increased manufacturing and SG&A costs are concerns.
Things You Must Know Ahead of Conagra's (CAG) Q3 Earnings
by Zacks Equity Research
Conagra's (CAG) third-quarter fiscal 2020 results are likely to reflect weaker-than-anticipated category performance.
Here's All You Must Note Ahead of McCormick (MKC) Q1 Earnings
by Zacks Equity Research
McCormick's (MKC) first-quarter fiscal 2020 results are likely to reflect gains from innovation and savings from the CCI program. However, volatile currency movements are concerning.
Church & Dwight Facilities Operational Even Amid Coronavirus
by Zacks Equity Research
Church & Dwight's (CHD) production facilities and distribution centers are operational amid the coronavirus outbreak.
Soap & Cleaning Materials Stocks Afloat Amid Coronavirus Crisis
by Rajani Lohia
The Soap & Cleaning Materials space stands to gain from the coronavirus-led hike in demand for disinfectants and cleansing agents in the near term.
Why Is Church & Dwight (CHD) Down 4.5% Since Last Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Church & Dwight Gains on International Unit, Brand Strength
by Zacks Equity Research
Church & Dwight's (CHD) Consumer International segment has been contributing to the company's organic sales growth for a while. However, high SG&A and marketing costs are a concern.
Church & Dwight (CHD) Q4 Earnings Meet Estimates, Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) Q4 sales improve on benefits from category growth and market share gains. However, earnings decline year over year.
Church & Dwight (CHD) Q4 Earnings Match Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 0.00% and 0.21%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Factors to Know Ahead of Church & Dwight's (CHD) Q4 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) Q4 performance is likely to have benefited from international business strength, acquisitions and market share gains.
Earnings Preview: Church & Dwight (CHD) Q4 Earnings Expected to Decline
by Zacks Equity Research
Church & Dwight (CHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Things to Note Ahead of Kimberly-Clark's (KMB) Q4 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter 2019 results are likely to reflect gains from Global Restructuring Program and FORCE Program. However, softness in the K-C Professional segment is a worry.
What's in Store for Procter & Gamble (PG) in Q2 Earnings?
by Zacks Equity Research
Procter & Gamble's (PG) second-quarter fiscal 2020 results are likely to reflect gains from organic sales and growth initiatives. Adverse currency might have been a drag.
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
by Rajani Lohia
The FMCG space gains from continued investment in brands, innovation, cost-containment and pricing actions. Escalating operating costs and unfavorable currency rates are headwinds.
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.
Clorox (CLX) Beats Q1 Earnings Estimates, Sales Miss (Revised)
by Zacks Equity Research
Clorox (CLX) reports earnings beat in first-quarter fiscal 2020. However, sales miss estimates on higher trade promotional spending, unfavorable mix, and adverse currency rates.
Clorox (CLX) Beats Earnings & Sales Estimates in Q1 (revised)
by Zacks Equity Research
Clorox (CLX) reports first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.